首页> 外文期刊>Journal of Business Research >PTE, innovation capital and firm value interactions in the biotech medical industry
【24h】

PTE, innovation capital and firm value interactions in the biotech medical industry

机译:生物技术医疗行业中的PTE,创新资本和企业价值互动

获取原文
获取原文并翻译 | 示例
           

摘要

Unlike previous studies which only focus on the main effect between IC and FV, this research includes PTE with the gap of resource-based view. IC is a key element in creating a competitive advantage, as it has a great influence on FV. A company may put relatively less into IC if it demonstrates higher efficiency. However, previous studies have neglected the fact that relative efficiency and IC affect FV and stock returns directly and indirectly. The research period was from 2006 to 2010 and the main research methods include HRA and DEA. The main research findings include the following. (1) There is a space for improvement in terms of the total technical efficiency. (2) PTE has a significant moderating effect between IC and FV. (3) IC and PTE have a significant influence on FV. (4) Apart from PTE and stock returns, IC and FV show significant differences within the sub-industry.
机译:与以前的研究仅关注IC和FV之间的主要影响不同,本研究将PTE与基于资源的观点相提并论。 IC是创造竞争优势的关键要素,因为它对FV有很大影响。如果一家公司展示出更高的效率,那么它在IC方面的投入可能会相对较少。但是,以前的研究忽略了相对效率和IC直接或间接影响FV和库存收益的事实。研究期间为2006年至2010年,主要研究方法包括HRA和DEA。主要研究结果如下。 (1)在整体技术效率方面还有改进的空间。 (2)PTE在IC和FV之间具有显着的调节作用。 (3)IC和PTE对FV有重大影响。 (4)除了PTE和股票收益外,IC和FV在子行业内也显示出显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号